13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-06-01 Event 2026-05-27 SEC 0001493152-26-026642 →

Van Hoose Kyri K. Dermata Therapeutics, Inc. DRMAW

Stake: 9.00% Shares: 384,352 CUSIP: 249845504 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

The Reporting Person acquired the securities reported herein for investment purposes. The Reporting Person reserves the right to acquire, or cause to be acquired, additional securities of the Issuer, to dispose of, or cause to be disposed of, such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of general investment and trading policies of the Reporting Person, market conditions or other factors. The Reporting Person serves as Chief Financial Officer of the Issuer, and in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Person reserves the right to change her purpose and to formulate and implement plans or proposals with respect to the Issuer at any time and from time to time. Any such action may be made alone or in conjunction with other shareholders, potential acquirers, financing sources and/or other third parties and could include one or more purposes, plans or proposals that relate to or would result in actions required to be reported herein in accordance with Item 4 of Schedule 13D. Other than as described herein, the Reporting Person currently has no plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a) through (j) of Schedule 13D.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 5.09
4,197 shares short · +13.5% vs prior

Post-Filing Returns · since 2026-05-27 on DRMAW

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
+90 days
+180 days

Anchor price 0.02 on closest trading day on/after 2026-05-27. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Dermata Therapeutics, Inc.

FiledFormFilerStakeShares
2026-01-08 SCHEDULE PROEHL GERALD T 24.70% 694,530 view →
2025-04-03 SCHEDULE PROEHL GERALD T 7.80% 804,098 view →
2025-02-13 SCHEDULE PROEHL GERALD T 15.00% 803,751 view →
2025-01-23 SCHEDULE PROEHL GERALD T 16.00% 803,751 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →